BGI visiting BME SUSTech

Co-founder and President of Beijing Genome Institute (BGI), Dr. Wang Jian, along with Dr. Yu Hao , supervisor of the BGI group Board Office visited the SUSTech Department of Biomedical Engineering (BME SUSTech) on the 7th of December evening. Assoc. Professor Chen Fangyi, Assoc. Professor Likai, Asst. Professor Guo Qiongyu, Asst. Professor Ho Chun Loong, Asst. Professor Liu Chao and Miss Deng Dandan were in attendance to welcome the BGI entourage, aiming to foster closer collaborative ties through the many research projects that are ongoing in the various laboratories.

President Wang highlighted the various potential collaborative work in multi-omic analysis with key foci on proteomic, metagenomic, and transcriptomic analysis. The multi-omic research provides tools to help further propel the development and later commercialization of the technologies established in BME SUSTech. President Wang emphasized his intent to further contribute to the Pearl Delta region’s growth and research advancement through closer collaboration with SUSTech. Preliminary discussions include many key research work within the department’s main research areas, including mechanomedicine, multiscale/multimodal biomedical imaging, wearable devices and wireless monitoring, biomedical MEMS, de novo regenerative engineering, computational medicine for big data, and health informatics. This BGI-BME SUSTech visit embodies both parties’ commitment to the continual collaboration to thrust the technological development and nurturing of specialized-trained workforce within the region.

The BGI-BME SUSTech visit. (from left to right: Assoc. Professor Likai, Asst. Professor Guo Qiongyu, President Wang Jian, Asst. Professor Liu Chao, Assoc. Professor Chen Fangyi, Asst. Professor Ho Chun Loong)

President Wang Jian (second from the right) and Dr. Yu Hao (center) explaining BGI’s latest technological advancement to the members of SUSTech BME.

Asst. Professor Ho Chun Loong explaining his research work to President Wang Jian and Dr. Yu Hao during their visit to his laboratory.

 

Reported by DENG Dandan

SUSTech researchers create super-resolution “street view” of intracellular organelles’ interactions

The study of organelles’ dynamics and their interactions have been limited by optical diffraction. Recently, teams from the Chair Prof. Dayong Jin at SUSTech and Prof. Xi Peng (Peking University) successfully created a super-resolution “street view” of intracellular organelles’ interactions and has this published in Nature Communications.

This is the first time that researchers get the dynamics of lipid heterogeneity inside subcellular organelles with optical imaging technology. They have developed a Spectrum and Polarization Optical Tomography (SPOT) technique, which can resolve the membrane morphology, polarity, and phase from the intensity, spectrum, and polarization, respectively. Combined with lipophilic probes, the team successfully revealed more than ten types of organelles simultaneously and analyzed their sophisticated lipid dynamics.

A cell is a self-efficient “micro-world” with various organelles responsible for nutrition import, metabolism, endocrine modulation, protein manufacturing, waste transportations, and all the efficient communications. The study of organelles’ dynamics and their interactions will help us understand the cell functions and diagnose the cause of diseases, as well as develop potential drug treatments. As widely-used fluorescence microscopy has limits in the color and type of fluorescent dyes and in temporal and spatial resolutions, it is extremely difficult to get simultaneous imaging of multiple organelle species.

Lipid membranes in subcellular compartments synergistically regulate biophysical membrane properties, membrane protein function, and lipid-protein interactions. Despite its significant role in biochemical function and interaction of subcellular organelles, due to their similar chemical composition, it is challenging to study the classification and interaction of different types of lipid membranes and observe their dynamics for a long time.

Compared with the other existing fluorescence microscopy techniques, SPOT is superior in optical throughput that correlatively obtains the high-dimensional information from six raw images within tens of milliseconds. SPOT’s optical section ability improves the measurement accuracy of polarity and phase. This is the first time that researchers quantitatively study the lipid heterogeneity inside subcellular organelles.

Figure 1 Heterogeneity of subcellular lipid membranes revealed by SPOT.

With SPOT, the lipid heterogeneity on the outer membrane and the cristae of mitochondria, as well as lipid dynamics through endosome maturation, can be clearly imaged in real-time. With the new imaging platform established at SUSTech, researchers observed the multi-organelle interactive activities of cell division, lipid dynamics during the plasma membrane separation, tunneling nanotubules formation, and mitochondrial cristae dissociation.

Figure 2 Time-lapse high-dimensional super-resolution imaging of the late-stage division of two U2-OS cells

Figure 3 Dynamic changes of lipid membrane during mitochondrial cristae dissociation

Most microscopes can only image four or fewer color channels, far less than the types of intracellular organelles. The synergistic use of membrane morphology, lipid polarity, and the lipid phase can classify more than ten types of organelles.

SUSTech Research Assistant Professor Karl Zhanghao is the co-first author and the co-corresponding author of the work. His contribution includes: (1) Super-resolution Dipole Orientation Mapping (SDOM) technique, (Light: Sci. Appl. 2016, https://doi.org/10.1038/s41467-019-12681-w, highlighted by Nat. Methods, https://doi.org/10.1038/nmeth.4061); (2) polarized Structured Illumination Microscopy (pSIM) technique, (https://10.1038/s41467-019-12681-w, highlighted by Nat. Methods, https://doi.org/10.1038/s41592-019-0682-6); (3) pSIM with improved imaging resolution (Opt. Express, https://doi.org/10.1364/OE.395092), and low-cost SIM with laser interference and digital micro-mirror device (Appl. Phys. Lett. 2020, https://doi.org/10.1063/5.0008264).

Doctoral students Wenhui Liu from Tsinghua University, and Meiqi Li from Peking University are the co-first authors of this work.

This work has been supported by the National Natural Science Foundation of China, National Key Research and Development Program of China, Beijing Natural Science Foundation, and Shenzhen Science and Technology Program.

Article Link:https://doi.org/10.1038/s41467-020-19747-0

SUSTech professors achieve breakthrough in electronic blood vessels

Chen HANG, Ran XIAO | 10/27/2020 27
 

Researchers from Southern University of Science and Technology (SUSTech) and Fuwai Hospital of the Chinese Academy of Medical Sciences ( referred to as “Fuwai Hospital”) have developed electronic blood vessels that can be actively tuned to address subtle changes in the body after implantation. The research, published in the journal Matter, entitled “Electronic Blood Vessel.”

By using poly(L-lactide-co-ε-caprolactone) (PLC), the electronic blood vessels are made to encapsulate liquid metal to achieve the flexible and biodegradable circuit. It could also overcome the limitations of conventional tissue-engineered blood vessels (TEBVs), which serve as passive scaffolds., This could be achieved by coordinating with other electronic devices to deliver genetic material, enable controlled drug release, and facilitate the formation of new endothelial blood vessel tissue.

The electronic blood vessels could integrate flexible electrons with three layers of blood vessel cells to imitate and surpass natural blood vessels. It can effectively promote cell proliferation and migration in the wound healing model through electrical stimulation. It can controllably deliver genes to specific parts of the blood vessel through electro-transfection. Through a 3-month in vivo study of the rabbit carotid artery replacement model, the authors evaluated the electronic blood vessel’s efficacy and biological safety in the vascular system. They confirmed its patency through ultrasound imaging and angiography. The research paves the way for the integration of flexible, degradable bioelectronics into the vascular system, which can be used as a platform for further treatments, such as gene therapy, electrical stimulation, and electronically controlled drug release.

Electronic blood vessels show the potential to play a key role in the treatment of cardiovascular disease. In the treatment of cardiovascular disease through coronary artery bypass grafting, the existing small diameter (<6 mm) tissue-engineered blood vessels (TEBV) have not yet met clinical needs. The methods used in most studies only provide TEBV with a stent that provides mechanical support, which mainly relies on the remodeling process of host tissues but has obvious limitations in helping to regenerate new blood vessels. Specifically, the complex interaction between blood flow and TEBV usually causes resonance reactions, leading to problems such as thrombus formation and neointimal hyperplasia. Instead, the new generation of TEBV should have enough apical stents to provide mechanical support and the ability to respond and integrate with the remodeling process actively to provide adaptive treatment after implantation.

In Situ Monitoring of the Electronic Blood Vessel

(A) Schematic of the electronic blood vessel in the carotid artery of the rabbit.
(B and C) An end-to-end anastomosis procedure of electronic blood vessel implantation in carotid arteries of rabbits (n = 6). The dotted frames (B and C)outline the margin of the native carotid artery and the implanted electronic blood vessel. The white arrows (C) indicate the two ends of the electronic blood vessel. Scale bar, 1 cm.
(D–G) In situmonitoring of the electronic blood vessel by Doppler ultrasound imaging 3 months post-implantation. Representative images from at least three different animals. (D and E) The real-time blood flow at the operational site and the synchronized ultrasound pulses. The asymmetric velocity curve indicates that the signal is from the carotid artery rather than the vein. (E) Zoom-in view of red box in (D). (F) The cross-sectional view of the blood flow.
(G) The suture site (red arrows) connecting the native carotid artery and the electronic blood vessel.
(H) The diameter changes in the electronic blood vessel at different times post-implantation.
(I) The velocity of blood flow at the operational site (n = 18, from different rabbits at different time points).
(J and K) In situ monitoring by arteriography 3months post-implantation. (J) Image before injecting the contrastmedium. Red box indicates the position of the implanted electronic blood vessel. Scale bar, 1 cm.
(K) Image after injecting the contrast medium. Red box indicates the position of the implanted blood vessel. Red arrows indicate the suture sites connecting the native carotid artery and the electronic blood vessel. Scale bar, 1 cm.

The team uses a PTFE mandrel, forming a 3D multi-layered tubular structure with PLC-based metal-polymer conductor (MPC) membranes. The inner diameter of the electronic blood vessel is about 2 mm, which is flexible and degradable. The MPC circuit has excellent conductivity and can be well distributed in the three-dimensional multilayer tubular structure. Studies have found that electronic blood vessels also have excellent cell safety, including the three cultured vascular cells (human umbilical vein endothelial cells, human aortic smooth muscle cells, and human aortic fibroblasts).

The team also constructed a 3D electrical function model to stimulate endothelial cells in vitro through electrochemical workstations to promote their proliferation and migration. Simultaneously, three kinds of blood vessel cells were patterned on the 3D electronic blood vessel, and the GFP plasmid was electroporated in vitro by an electroporation instrument. After two days of culture, the expression of the plasmid was observed.

The team chose rabbits from New Zealand as the animal model, replacing the common carotid artery with electronic blood vessels. The implanted electronic blood vessels were monitored by Doppler ultrasound imaging and arteriography. According to Doppler ultrasound imaging, three months after implantation, the electronic blood vessel allows stable blood flow to pass, showing the electronic blood vessel’s excellent patency. In the future, the electronic blood vessel can be integrated with other electronic components and devices to achieve diagnostic and therapeutic functions. This will enhance significantly personalized medical functions by establishing a direct connection in the blood vessel tissue-machine interface.

Shiyu Cheng, Chen Hang, and Li Ding are the joint first authors of the paper, and Yan Zhang (Fuwai Hospital) and Xingyu Jiang (SUSTech)are the corresponding authors.

Link to the paper: https://www.sciencedirect.com/science/article/pii/S2590238520304938

Improving quality of biomedical imaging with new agents

Chris Edwards | 10/03/2020 40

Optical imaging has emerged as one of the promising imaging techniques in both research and clinical practice. Photoacoustic imaging and fluorescent imaging are the two leading representatives of optical-related imaging approaches. Their imaging qualities highly rely on contrast agents. The ideal photoacoustic and fluorescent agent is still to be found. The theoretical system that guides the construction of efficient contrast agents has not been widely established.

Associate Professor Kai Li (Biomedical Engineering – BME) teamed up with several research teams. They have made significant progress in designing near-infrared two-zone imaging materials and biomedical diagnosis. Their research outcomes have been published in Angewandte Chemie International Edition (Angew Chem Int Ed), Biomaterials, and Research.

The teams verified their design concepts and strategies through theoretical calculations. They obtained various high-performance photoacoustic and fluorescent imaging materials with optical activity in the second near-infrared window (NIR-II, 1000-1700 nm). They have applied them in different research fields, such as vascular imaging and tumor detection.

The first paper at Angew Chem Int Ed. was titled “An Ester‐substituted Semiconducting Polymer with Efficient Nonradiative Decay Enhances NIR‐II Photoacoustic Performance for Monitoring of Tumor Growth.”

The research teams synthesized several thiadiazoloquinoxaline (TQ)-based semiconducting polymers (SPs) with a broad absorption covering the NIR-I to NIR-II regions. The excited s-BDT-TQE shows a large dihedral angle, narrow adiabatic energy, and low radiative decay. It is attributed to the strongly electron-deficient ester-substituted TQ-segment.

The more vigorous molecular motions trigger higher reorganization energy. They yield an efficient photo-induced nonradiative decay. BDT-TQE SP-cored nanoparticles with twisted intramolecular charge transfer (TICT) exhibit a high NIR-II photothermal conversion efficiency (61.6%). They also exhibit the preferable PA tracking in-situ hepatic tumor growth for more than 20 days.

The research teams proposed a new approach that adjusted the TICT effect in polymer chains for augmented PNRD property. It enhanced the photothermal conversion & photoacoustic performance for monitoring in-situ tumor growth in mice.

BME masters student Menglei Zha is the co-first author, along with City University of Hong Kong (CityU) Dr. Xiangwei Lin and National Kaoshiung University of Science and Technology (NKUST), Professor Jen-Shyang Ni. Dr. Kai Li is a co-corresponding author of this paper, with CityU Professor Lidai Wang and NKUST Dr. Jen-Shyang Ni.

The authors are grateful to the National Natural Science Foundation of China, Guangdong Innovative and Entrepreneurial Research Team Program, the Shenzhen Science and Technology Program, Research Grants Council of the Hong Kong Special Administrative Region, and Fundamental Research Funds for the Central Universities for financial support. The authors also acknowledge the Center for Computational Science and Engineering at SUSTech for theoretical calculation support and SUSTech Core Research Facilities for their technical support.

Figure 1. Improve the nonradiative transition efficiency of semiconductor polymers to achieve long-term real-time monitoring of tumor growth via NIR-II photoacoustic imaging

The paper published in Biomaterials was titled, “Self-assembled AIEgen nanoparticles for multi-scale NIR-II vascular imaging.” It looked at how fluorogens with aggregation-induced emission (AIEgens) have been intensively explored in biomedical applications.

One primary strategy to bring these hydrophobic AIEgens into the aqueous biological environment is to encapsulate them in nanoparticles with functionalized polymeric matrices. Most fluorophores are insoluble in water, requiring post-modification like amphiphilic polymer encapsulation. The traditional preparation of AIEgen nanoparticles is convenient. These methods are hard to fulfill the required uniform size and stable loading efficiency. The exploration of reliable strategies that can afford AIE nanoparticles with the above requirements with minimized batch-to-batch variation remains challenging.

The research team designed amphiphilic AIEgens, built with a hydrophobic donor-acceptor-donor (D-A-D) core and hydrophilic polyethylene glycol (PEG) chain. These AIEgens can self-assemble into uniform nanoparticles with average sizes of ~35 nm, showing an emission maximum beyond 1000 nm and quantum yields (QYs) above 10%. The team used the bright AIE nanoparticles for multi-scale intravital vascular fluorescence imaging in the second near-infrared window (NIR-II, 1,000-1,700 nm) in mouse and rabbit models.

Advanced AIE nanoparticles with efficient self-assembly strategies were constructed for angiography. The early stages of demonstration for the AIEgen nanoprobes for NIR-II imaging in large animal models (rabbits with an average weight of 3 kg) will inspire more research opportunities in designing advanced NIR-II probes and promoting the translational studies of this emerging imaging technique.

BME doctoral student Yaxi Li and Shenzhen Institute of Advanced Technology (SIAT) Dr. Dehong Hu are the co-first authors. Dr. Kai Li and SIAT Dr. Hairong Zhang are the co-corresponding authors of this paper.

This work was supported by the National Natural Science Foundation of China, Guangdong Innovative and Entrepreneurial Research Team Program, the Science and Technology Innovation Committee of Shenzhen Municipality, the Shenzhen key laboratory of ultrasound imaging and therapy, and CAS key laboratory of health informatics. The authors also acknowledge the Center for Computational Science and Engineering at SUSTech for theoretical calculation support and SUSTech Core Research Facilities for technical support.

Figure 2. Self-assembly strategy to prepare aggregation-induced luminescence nanoprobes to achieve multi-scale NIR-II vascular imaging

The paper published in Research was titled, “Centimeter-Deep NIR-II Fluorescence Imaging with Nontoxic AIE Probes in Non-Human Primates.” In biomedical fluorescence imaging, AIEgens plays an increasingly important role. However, there is still a lack of in-depth toxicological research and deep imaging evaluation in primate models.

The research team studied the high intravenous injection dose of AIE probes, 30 times the standard clinical dosage in primate blood and histological analysis report. The results showed that the AIE probes were in the normal range after 35 days of metabolism in primates, which proved that the AIE probes were not biologically toxic. The research team also utilized the biological safety and high-brightness optical performance of the AIE probe. They successfully achieved a depth of 1.5cm blood vessel imaging in primates, breaking the current limit of near-infrared two-zone fluorescence imaging at the millimeter level.

The two features of NIR-II AIE probes enable them to become promising fluorophore candidates for angiography and lymphadenopathy. They could pave the way to promote clinical translation of NIR-II AIE probes in human clinical trials.

Dr. Kai Li is a co-corresponding author of this paper, with the Hong Kong University of Science and Technology (HKUST) Professor Ben Zhong Tang and SIAT Dr. Hairong Zheng. Additional contributions came from the National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital & Shenzhen Hospital.

Figure 3. The NIR-II AIE probe achieves high signal-to-noise ratio blood vessel imaging in primates with a depth of 1.5 cm

The second paper published in Angew Chem Int Ed. was titled “Sub‐10 nm Aggregation‐Induced Emission Quantum Dots Assembled by Microfluidics for Enhanced Tumor‐Targeting and Reduced Retention in the Liver.” AIE dots (AIE dots) obtained by hybridization with phospholipids have been widely used in biomedical imaging. However, the particle size of the AIE dots prepared in this traditional method is usually larger than 25 nm. Due to the interception of the liver, spleen, and other organs, the ideal imaging effect is often difficult to obtain with such large AIE dots.

The research team developed a microfluidic chip with a double spiral mixing pipe (pipe width 300 microns, height 60 microns) to prepare AIE nanoparticles. These are known as AIE quantum dots (QDs), separate from the larger AIE dots. AIE QDs allow more efficient cellular uptake and imaging without surface modification of any membrane-penetrating peptides or other targeting molecules.

NIR-II AIEgens were used to demonstrate that AIE QDs can achieve high contrast at the tumor as small as 80 mm3 and evade the liver more efficiently than AIE dots.

The sub-10 nm organic AIE QDs were successfully synthesized in a microfluidic chip, showing better in-vitro and in-vivo solid-tumor imaging than AIE dots. These AIE QDs promises a pathway for efficient cell labeling and sensitive & precise detection of the tumor. The microfluidic method may help make a broad range of multi-function AIE molecules into sub-10 nm AIE QDs. They could have immense potential in diverse biological applications.

Doctor Xuanyu Li from the University of the Chinese Academy of Sciences (UCAS) is the first author, and Menglei Zha is the co-first author. Dr. Kai Li is a co-corresponding author. Additional contributions came from the BME Microfluidic Research laboratory.

The research teams thank the National Key R&D Program of China, the National Natural Science Foundation of China, the Chinese Academy of Sciences, the Guangdong Innovative and Entrepreneurial Research Team Program, the Science and Technology Innovation Committee of Shenzhen Municipality, and the Tencent Foundation through the XPLORER PRIZE for financial support. The authors also acknowledge the Center for Computational Science and Engineering at SUSTech for theoretical calculation support and SUSTech Core Research Facilities for technical support.

Figure 4. The new microfluidic synthesis strategy prepares sub-10 nm AIE QDs to reduce liver retention and enhance tumor targeting in tumor-bearing mice.

 

Related links:

https://onlinelibrary.wiley.com/doi/abs/10.1002/anie.202010228

https://www.sciencedirect.com/science/article/pii/S0142961220306116

https://doi.org/10.34133/2020/4074593

https://onlinelibrary.wiley.com/doi/10.1002/anie.202008564

Science Technology and Innovation Commission delegation visits SUSTech

Chris Edwards | 09/09/2020

 

In recent days, Shenzhen Municipal Science, Technology, and Innovation Commission (STIC) Deputy Director Xuan QIU led a delegation to the Department of Biomedical Engineering (BME) at Southern University of Science and Technology (SUSTech). SUSTech University Council Chairperson Yurong GUO met with the STIC delegation, along with long-term distinguished visiting BME professor Daping WANG.

At the meeting, SUSTech University Council Chairperson Yurong GUO said that SUSTech’s rapid and high-quality development is inseparable from the support of the city, the province, and the state. The ongoing support from STIC for SUSTech’s development highlights its continuing commitment to “research, innovation, and entrepreneurship.” It will focus on the development of its talent pipeline, the transformation of its technology, and global cooperation to continue to contribute to the progress of Shenzhen.

STIC Deputy Director Xuan QIU affirmed the developments SUSTech and BME has made in recent years. She spoke about the policies to promote the development of the bioengineering and pharmaceutical industry in Shenzhen. She pointed out that the biological and life health industry is one of the most dynamic emerging industries in the world. Numerous advantages are available to SUSTech, so the ongoing scientific and technological work conducted at SUSTech would encourage the implementation of the strategic goals for regional development.

SUSTech Acting Vice President Yusheng ZHAO and Office of Research Deputy Director Yi GONG introduced the major scientific progress of SUSTech and related research projects. BME head Xingyu JIANG spoke about the teaching and research achievements of the department. He said that it would continue to integrate world-class technologies with more robust cooperation with Shenzhen enterprises.

Long-term distinguished visiting BME professor Daping WANG said that BME would continue to build several international exchanges and cooperation platforms. It will improve the level of international cooperation and exchange. They will conduct extensive scientific research exchanges and technology transformations for the city’s sustainable development.